共 168 条
[1]
Karran E(2011)The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics Nat Rev Drug Discov 10 698-712
[2]
Mercken M(2002)The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics Science 297 353-356
[3]
De Strooper B(1991)The molecular pathology of Alzheimer’s disease Neuron 6 487-498
[4]
Hardy J(2012)An effector-reduced anti-β-amyloid (Aβ) antibody with unique Aβ binding properties promotes neuroprotection and glial engulfment of Aβ J Neurosci 32 9677-9689
[5]
Selkoe DJ(2016)Structure of crenezumab complex with Aβ shows loss of β-hairpin Sci Rep 6 39374-566
[6]
Selkoe DJ(2015)Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region J Nucl Med 56 560-459
[7]
Adolfsson O(2015)Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction NeuroImage 108 450-574
[8]
Pihlgren M(2015)Measurement of longitudinal β-amyloid change with 18F-florbetapir PET and standardized uptake value ratios J Nucl Med 56 567-e1897
[9]
Toni N(2018)ABBY: a phase 2 randomized trial of crenezumab in mild-to-moderate Alzheimer’s disease Neurology 90 e1889-198
[10]
Varisco Y(1975)“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189-1095